42
Views
9
CrossRef citations to date
0
Altmetric
Original article

Deviations in coagulation activation due to treatment with different haemodialysis membranes

, , &
Pages 417-424 | Received 24 Mar 2003, Accepted 13 Jun 2003, Published online: 08 Jul 2009

REFERENCES

  • Bartels PCM, Schoorl M, Schoorl M, Wiering JGA, Nubé MJ. Activation of coagulation during treatment with haemodialysis. Scand J Clin Lab Invest 2000; 60: 283–90.
  • Schouten WEM, Grooteman MPC, van Houte AJ, Schoorl M, Van Limbeek J, Nubé MJ. Effects of dialyzer and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 2000; 15: 379–84.
  • Schindler R, Boenisch 0, Fisher C, Frei U. Effect of hemodialysis membranes on the inflammatory reaction in vivo. Clin Nephrol 2000; 53: 452–9.
  • Lindhout T. Biocompatibility of extracorporeal blood treatment. Selection of hemostatic para-meters. Nephrol Dial Transpl 1994; 9 Suppl. 2: 83–9.
  • Ward RA. Effects of haemodialysis on coagula-tion and platelets: are we measuring membrane biocompatibility? Nephrol Dial Transpl 1995; 10: 12 — 7.
  • Ambilhl R, Wiithrich RP, Korte W, Schmid L, Krapf R. Plasma hypercoagulability in haemodia-lysis patients: impact of dialysis and anticoagula-tion. Nephrol Dial Transplant 1997; 12: 2355— 64.
  • Sloand JA, Sloand EM. Studies on platelet membrane glycoproteins and platelet function during haemodialysis. J Am Soc Nephrol 1997; 8: 799–803.
  • Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503–21.
  • Ravanat C, Freund M, Mangin P, Azorsa DO, Schwartz C, Moog S, Schuhler S, Dambach J, Cazenave J-P, Lanza F. GP-V is a marker of in vivo platelet activation—study in a rat thrombosis model. Thromb Haemost 2000; 83: 327–33.
  • Grooteman MPC, van Tellingen A, van Houte AJ, Bos JC, Schoorl M, van Limbeek J, Nubé MJ. Haemodialysis-induced degranulation of poly-morphonuclear cells: no correlation between membrane markers and degranulation products. Nephron 2000; 85: 267–74.
  • Svensson M, Friberger P, Lundstrom 0, Stegmayr B. Activation of FXII during haemodialysis. Scand J Clin Lab Invest 1996; 56: 649–65.
  • Opatmy K, Bouda M, Kohoutkova L, Vit L, Sefma F. A Clinical study to assess the effect of heparin in dialyzer rinsing solutions. Int J Artif Organs 1997; 20: 112–8.
  • Llach F. Hypercoagulability, renal vein thrombo-sis and other thrombotic complications of nephro-tic syndrome. Kidney Int 1985; 36: 272–9.
  • Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 43: S237— S44.
  • Wardle EN, Percy DA. Studies of contact acti-vation of blood in haemodialysis. J Clin Pathol 1972; 25: 1045–9.
  • Kroll MH. Mechanisms of coagulation. In: Kroll MH. Manual of coagulation disorders. London: Blackwell Science Inc; 2001. p. 1–8.
  • Sultan Y, London GM, Goldfarb B, Toulon P, Marchais SJ. Activation of platelets. Coagulation and fibrinolysis in patients on long-term haemo-dialysis: influence of cuprophan and polyacryloni-trile membranes. Nephrol Dial Transplant 1990; 5: 362 — 8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.